Skip to main content

Remote Job Finders (RJF)

Forge’s Piteri-Molina on AI, Ohio and what’s next for gene therapy manufacturing

The BioSpace 40 Under 40 honoree helped steer Forge’s sale to Ajinomoto. Now, Samantha Piteri-Molina sees opportunities in AI-driven analytics and Ohio’s gene therapy ecosystem—with a responsibility to patients worldwide.

Evommune inks molecular glue deal worth $1.1B biobucks to fill pipeline gap

Evommune is commiting $30 million upfront for Hinova Pharmaceuticals’ oral molecular glue degrader—a low-cost bet with a high probability of success, according to analysts, after clinical failures roiled the biotech’s internal pipeline earlier this year.
Scroll to top